Potential value of protocols in substantially bleeding trauma patients

Current Opinion in Anaesthesiology

Volumn 26, Issue 2, 2013, Pages 215-220

  Holcomb, John B ^a   Gumbert, Sam ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

acute trauma shock; blood component ratios; substantial bleeding protocols

Indexed keywords

FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DISEASE SEVERITY; ERYTHROCYTE; FLUID RESUSCITATION; HEALTH CARE DELIVERY; HUMAN; INTRAOPERATIVE PERIOD; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SUBSTANTIAL BLEEDING PROTOCOL; SYSTEMATIC REVIEW (TOPIC); TRAUMATIC SHOCK;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CLINICAL PROTOCOLS; HEMORRHAGE; HUMANS; THROMBELASTOGRAPHY; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84874945713     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32835e8c9b     Document Type: Review

References (69)

1. Center for Disease Control and Prevention. Ten leading causes of death and injury. http://www.cdc.gov/injury/wisqars/LeadingCauses.html [Accessed 21 January 2013]
2. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995; 38:185-193.
3. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998; 186:528-533.
4. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60 (Suppl 6):S3-S11.
5. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54:1127-1130.
6. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003; 55:39-44.
7. Wudel JH, Morris JA Jr, Yates K, et al. Massive transfusion: outcome in blunt trauma patients. J Trauma 1991; 31:1-7.
8. Grounds RM, Seebach C, Knothe C, et al. Use of recombinant activated factor VII (Novoseven) in trauma and surgery: analysis of outcomes reported to an international registry. J Intensive Care Med 2006; 21:27-39.
9. Holcomb JB, Spinella PC. Optimal use of blood in trauma patients. Biologicals 2010; 38:72-77.
10. Cotton BA, Gunter OL, Isbell J, et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64:1177-1182; discussion 1182-1183.
11. Hess JR, Dutton RB, Holcomb JB, Scalea TM. Giving plasma at a 1:1 ratio with red cells in resuscitation: who might benefit? Transfusion 2008; 48:1763-1765.
12. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447-458.
13. Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010; 50:493-500.
14. Spinella PC, Perkins JG, Grathwohl KW, et al. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 2008; 64 (Suppl 2):S69-S77; discussion S77-S78.
15. Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 h of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009; 197:565-570; discussion 570.
16. Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012; 99 (Suppl 1):40-50.
17. Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 2005; 3:640-648.
18. Curry N, Davis PW. What's new in resuscitation strategies for the patient with multiple trauma? Injury 2012; 43:1021-1028.
19. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38:298-304.
20. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007; 13:680-685.
21. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245:812-818.
22. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43:26-32.
23. Ganter MT, Jean-François aP. New insights into acute coagulopathy in trauma patients. Best Pract Res Clin Anaesthesiol 2010; 24:15-24.
24. Jansen JO, Thomas R, Loudon MA, Brooks A. Damage control resuscitation for patients with major trauma. BMJ 2009; 338:b1778.
25. Duchesne JC, McSwain NE Jr, Cotton BA, et al. Damage control resuscitation: the new face of damage control. J Trauma 2010; 69:976-990.
26. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23:231-240.
27. Cannon WB. The preventive treatment of wound shock. JAMA 1918; 70:618.
28. Cirocchi R, Abraha I, Montedori A, et al. Damage control surgery for abdominal trauma. Cochrane Database Syst Rev 2010:CD007438.
29. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62:307-310.
30. Cotton BA, Reddy N, Hatch QM, et al. Damage control resuscitation is associated with a reduction in resuscitation volumesand improvement in survival in 390 damage control laparotomy patients. Ann Surg 2011; 254:598-605.
31. Shaz BH, Dente CJ, Harris RS, et al. Transfusion management of trauma patients. Anesth Analg 2009; 108:1760-1768.
32. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805-813.
33. Morse BC, Dente CJ, Hodgman EI, et al. Outcomes after massive transfusion in nontrauma patients in the era of damage control resuscitation. Am Surg 2012; 78:679-684.
34. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64 (Suppl 2):S79-85; discussion S85.
35. Nunez TC, Young PP, Holcomb JB, Cotton BA. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 2010; 68:1498-1505.
36. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009; 66:1616-1624.
37. Stawicki SP, Brooks A, Bilski T, et al. The concept of damage control: extending the paradigm to emergency general surgery. Injury 2008; 39:93-101.
38. Duchesne JC, Hunt JP, Wahl G, et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma 2008; 65:272-276; discussion 276-278.
39. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006; 60 (Suppl 6):S91-S96.
40. O'Keeffe T, Refaai M, Tchorz K, et al. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008; 143:686-690; discussion 690-691.
41. Riskin DJ, Tsai TC, Riskin L, et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009; 209:198-205.
42. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007; 62:112-119.
43. Sisak K, Soeyland K, McLeod M, et al. Massive transfusion in trauma: blood product ratios should be measured at 6 h. ANZ J Surg 2012; 82:161-167.
44. Hirshberg A, Dugas M, Banez EI, et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003; 54:454-463.
45. Ho AM, Karmakar MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg 2005; 190:479-484.
46. Kashuk JL, Moore EE, Johnson JL, et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma 2008; 65:261-270; discussion 270-271.
47. Murad MH, Stubbs JR, Gandhi MJ, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010; 50:1370-1383.
48. Teixeira PG, Inaba K, Shulman I, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009; 66:693-697.
49. Gunter OL Jr, Au BK, Isbell JM, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008; 65:527-534.
50. Curry NS, Davenport RA, Hunt BJ, Stanworth SJ. Transfusion strategies for traumatic coagulopathy. Blood Rev 2012; 26:223-232.
51. Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets: a review of the current literature. Transfusion 2010; 50:701-710.
52. Zehtabchi S, Nishijima DK. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009; 16:371-378.
53. Stansbury LG, Dutton RP, Stein DM, et al. Controversy in trauma resuscitation: do ratios of plasma to red blood cells matter? Transfus Med Rev 2009; 23:255-265.
54. de Biasi AR, Stansbury LG, Dutton RP, et al. Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma (CME). Transfusion 2011; 51:1925-1932.
55. Magnotti LJ, Zarzaur BL, Fischer PE, et al. Improved survival after hemostatic resuscitation: does the emperor have no clothes? J Trauma 2011; 70:97-102.
56. Snyder CW, Weinberg JA, McGwin G Jr, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 2009; 66:358-362; discussion 362-364.
57. Ho AM, Dion PW, Yeung JH, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology 2012; 116:716-728.
58. Holcomb JB, Del Junco DJ, Fox EE, et al. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. Arch Surg 2012 [Epub ahead of print]. doi:10.1001/2013.jamasurg.387
59. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, et al., Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376:23-32.
60. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377:1096-1101.
61. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012; 147:113-119.
62. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59:8-15; discussion 15-18.
63. Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010; 69:489-500.
64. Stanworth SJ, Birchall J, Doree CJ, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2007:CD005011.
65. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14:R55.
66. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83.
67. Nienaber U, Innerhofer P, Westermann I, et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011; 42:697-701.
68. Young PP, Cotton BA, Goodnough LT. Massive transfusion protocols for patients with substantial hemorrhage. Transfus Med Rev 2011; 25:293-303.
69. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256:476-486.